Strategic Partnerships Leverage Compass Point Research’s established collaborations with Pfizer, AbbVie, Gilead Sciences, Eli Lilly, Novavax, and Sanofi to position complementary services such as site feasibility, patient recruitment optimization, and end-to-end trial management for sponsor-led studies seeking efficient execution.

Network Expansion Target hospitals and provider groups that have already trusted Compass Point’s two-site model and rapid-start capabilities, plus expand outreach to additional mid-sized health systems seeking to bring industry-sponsored trials in-house for faster patient access.

Clinical Trial Enablement Promote the company’s track record of rapid start-up, strong enrollment, and high-quality data as a differentiator to sponsors aiming to reduce cycle times, improve data integrity, and accelerate device and drug trial timelines.

Tech-Driven Efficiency Highlight the existing tech stack and digital governance (Cloudflare, WordPress, Microsoft 365, secure practices) to offer sponsors scalable, compliant trial management platforms and streamlined communication workflows that support multi-site operations.

Financial Fit Position Compass Point as a cost-efficient partner in the mid-range revenue band with a lean team, appealing to sponsors seeking nimble trial management providers capable of delivering quality outcomes without large overhead.